-
Inflammatory protein associations with brain MRI measures: Framingham Offspring Cohort Alzheimers Dement. (IF 13.0) Pub Date : 2024-09-16 Jiachen Chen, Ahmed A. Y. Ragab, Margaret F. Doyle, Michael L. Alosco, Yuan Fang, Jesse Mez, Claudia L. Satizabal, Wei Qiao Qiu, Joanne M. Murabito, Kathryn L. Lunetta
Brain magnetic resonance imaging (MRI) and inflammatory biomarkers are crucial for investigating preclinical neurocognitive disorders. Current investigations focus on a few inflammatory markers. The study aims to investigate the associations between inflammatory biomarkers and MRI measures and to examine sex differences among the associations in the Framingham Heart Study.
-
Morphometry of medial temporal lobe subregions using high-resolution T2-weighted MRI in ADNI3: Why, how, and what's next? Alzheimers Dement. (IF 13.0) Pub Date : 2024-09-16 Paul A. Yushkevich, Ranjit Ittyerah, Yue Li, Amanda E. Denning, Niyousha Sadeghpour, Sydney Lim, Emily McGrew, Long Xie, Robin DeFlores, Christopher A. Brown, Laura E. M. Wisse, David A. Wolk, Sandhitsu R. Das
This paper for the 20th anniversary of the Alzheimer's Disease Neuroimaging Initiative (ADNI) provides an overview of magnetic resonance imaging (MRI) of medial temporal lobe (MTL) subregions in ADNI using a dedicated high-resolution T2-weighted sequence. A review of the work that supported the inclusion of this imaging modality into ADNI Phase 3 is followed by a brief description of the ADNI MTL imaging
-
Dysregulated FOXO1 activity drives skeletal muscle intrinsic dysfunction in amyotrophic lateral sclerosis Acta Neuropathol. (IF 9.3) Pub Date : 2024-09-16 Mónica Zufiría, Oihane Pikatza-Menoio, Maddi Garciandia-Arcelus, Xabier Bengoetxea, Andrés Jiménez, Amaia Elicegui, María Levchuk, Olatz Arnold-García, Jon Ondaro, Pablo Iruzubieta, Laura Rodríguez-Gómez, Uxoa Fernández-Pelayo, Mikel Muñoz-Oreja, Ana Aiastui, José Manuel García-Verdugo, Vicente Herranz-Pérez, Miren Zulaica, Juan José Poza, Rebeca Ruiz-Onandi, Roberto Fernández-Torrón, Juan Bautista
-
NMOSD and MOGAD: an evolving disease spectrum Nat. Rev. Neurol. (IF 28.2) Pub Date : 2024-09-13 Akiyuki Uzawa, Frederike Cosima Oertel, Masahiro Mori, Friedemann Paul, Satoshi Kuwabara
-
Correction to: Expanded clinical phenotype spectrum correlates with variant function in SCN2A-related disorders. Brain (IF 10.6) Pub Date : 2024-09-13
-
Inside out: the neural basis of spontaneous and creative thinking Brain (IF 10.6) Pub Date : 2024-09-13 Alizée Lopez-Persem, Emmanuel Mandonnet, Emmanuelle Volle
This scientific commentary refers to ‘Default mode network electrophysiological dynamics and causal role in creative thinking’ by Bartoli et al. (https://doi.org/10.1093/brain/awae199).
-
Decision cost hypersensitivity underlies Huntington’s disease apathy Brain (IF 10.6) Pub Date : 2024-09-13 Lee-Anne Morris, Kyla-Louise Horne, Sanjay Manohar, Laura Paermentier, Christina Buchanan, Michael MacAskill, Daniel Myall, Matthew Apps, Richard Roxburgh, Tim Anderson, Masud Husain, Campbell Le Heron
The neuropsychiatric syndrome of apathy is now recognized to be a common and disabling condition in Huntington’s disease (HD). However, the mechanisms underlying it are poorly understood. One way to investigate apathy is to utilise a theoretical framework of normal motivated behaviour, to determine where breakdown has occurred in people with this behavioural disruption. A fundamental computation underlying
-
Duration of Dual Antiplatelet Therapy in Acute Transient Ischemic Attack or Mild Ischemic Stroke: Are We Settled With 21 Days? Neurology (IF 7.7) Pub Date : 2024-09-13 Linxin Li
-
Core CSF Biomarker Profile in Cerebral Amyloid Angiopathy: Updated Meta-Analysis. Neurology (IF 7.7) Pub Date : 2024-09-13 Andreas Charidimou,Gregoire Boulouis
BACKGROUND AND OBJECTIVES There is a clear need to characterize and validate molecular biomarkers of cerebral amyloid angiopathy (CAA), in an effort to improve diagnostics, especially in the context of patients with Alzheimer disease (AD) receiving immunotherapies (for whom underlying CAA is the driver of amyloid-related imaging abnormalities). We performed an updated meta-analysis of 5 core CSF biomarkers
-
The Adverse Effects of Commonly Prescribed Antiseizure Medications in Adults With Newly Diagnosed Focal Epilepsy. Neurology (IF 7.7) Pub Date : 2024-09-13 Sarah N Barnard,Zhibin Chen,Andres M Kanner,Manisha G Holmes,Pavel Klein,Bassel W Abou-Khalil,Barry E Gidal,Jacqueline French,Piero Perucca,
BACKGROUND AND OBJECTIVES Systematic screening can help identify antiseizure medication (ASM)-associated adverse events (AEs) that may preclude patients from reaching effective doses or completing adequate trial periods. The Adverse Event Profile (AEP) is a self-completed instrument to identify the frequency of common AEs associated with ASM use. This study aimed to compare the AE profile of commonly
-
Association of Resilience-Related Life Experiences on Variability on Age of Onset in Dominantly Inherited Alzheimer Disease. Neurology (IF 7.7) Pub Date : 2024-09-13 Hye Joo Son,Jae Seung Kim,Randall J Bateman,Seonok Kim,Jorge J Llibre-Guerra,Gregory S Day,Jasmeer P Chhatwal,Sarah B Berman,Peter R Schofield,Mathias Jucker,Johannes Levin,Jae-Hong Lee,Richard J Perrin,John C Morris,Carlos Cruchaga,Jason Hassenstab,Stephen P Salloway,Jai-Hyuen Lee,Alisha Daniels,
BACKGROUND AND OBJECTIVES It remains unknown whether the associations between protective lifestyles and sporadic dementia risk reported in observational studies also affect age at symptom onset (AAO) in autosomal dominant Alzheimer disease (ADAD) with predominant genetic influences. We investigated the associations between resilience-related life experiences and interindividual AAO variability in ADAD
-
Cardiac CT vs Echocardiography for Intracardiac Thrombus Detection in Ischemic Stroke: A Systematic Review and Meta-Analysis of 43 Studies. Neurology (IF 7.7) Pub Date : 2024-09-13 Sherief Ghozy,Michael Liu,Hassan Kobeissi,Ali Mortezaei,Melika Amoukhteh,Alzhraa S Abbas,Adam A Dmytriw,Ramanathan Kadirvel,Alejandro A Rabinstein,David F Kallmes,Deena Nasr
BACKGROUND AND OBJECTIVES Ischemic stroke, a leading cause of mortality, necessitates understanding its mechanism for effective prevention. Echocardiography, especially transesophageal echocardiography (TEE), is the gold standard for detection of cardiac sources of stroke including left atrial thrombus, although its invasiveness, operator skill dependence, and limited availability in some centers prompt
-
Cardiac CT for Thrombus Detection: Prime Time for Stroke Patients? Neurology (IF 7.7) Pub Date : 2024-09-13 Luciano A Sposato,Jonathan M Coutinho
-
Association of Polygenic Risk Score With Lifetime Risk of Developing Multiple Sclerosis in a Population-Based Birth-Year Cohort. Neurology (IF 7.7) Pub Date : 2024-09-13 Floor C Loonstra,Daniel Álvarez Sirvent,Niccoló Tesi,Henne Holstege,Eva M M Strijbis,Alex N Salazar,Marc Hulsman,Sven J Van Der Lee,Bernard Uitdehaag
BACKGROUND AND OBJECTIVES More than 200 genetic variants have been associated with multiple sclerosis (MS) susceptibility. However, it is unclear to what extent genetic factors influence lifetime risk of MS. Using a population-based birth-year cohort, we investigate the effect of genetics on lifetime risk of MS. METHODS In the Project Y study, we tracked down almost all persons with MS (pwMS) from
-
Duration of Benefit and Risk of Dual Antiplatelet Therapy up to 72 Hours After Mild Ischemic Stroke and Transient Ischemic Attack. Neurology (IF 7.7) Pub Date : 2024-09-13 Ling Guan,Shangrong Han,S Claiborne Johnston,Philip M Bath,Pierre Amarenco,Yingying Yang,Tingting Wang,Jing Jing,Chunjuan Wang,Ying Gao,Weiqi Chen,Hongyi Yan,Xuan Wang,Yongjun Wang,Yilong Wang,Yuesong Pan
BACKGROUND AND OBJECTIVES Clopidogrel-aspirin initiated within 72 hours of symptom onset is effective in patients with mild ischemic stroke or transient ischemic attack (TIA) in the Intensive Statin and Antiplatelet Therapy for Acute High-risk Intracranial or Extracranial Atherosclerosis (INSPIRES) trial. Uncertainties remain about the duration of the treatment effect. This study aimed to assess duration
-
Editors' Note: Investigating the Prevalence of Comorbidity in Multiple Sclerosis Clinical Trial Populations. Neurology (IF 7.7) Pub Date : 2024-09-13 James E Siegler,Steven Galetta
-
Reader Response: Investigating the Prevalence of Comorbidity in Multiple Sclerosis Clinical Trial Populations. Neurology (IF 7.7) Pub Date : 2024-09-13 Lauren Grobois,Michelle You,Mill Etienne
-
Predicting CDR status over 36 months with a recall-based digital cognitive biomarker Alzheimers Dement. (IF 13.0) Pub Date : 2024-09-11 Davide Bruno, Ainara Jauregi-Zinkunegi, Jason R. Bock
Word-list recall tests are routinely used for cognitive assessment, and process scoring may improve their accuracy. We examined whether Alzheimer's Disease Assessment Scale–Cognitive subscale (ADAS-Cog) derived, process-based digital cognitive biomarkers (DCBs) at baseline predicted Clinical Dementia Rating (CDR) longitudinally and compared them to standard metrics.
-
Associations between misfolded alpha-synuclein aggregates and Alzheimer's disease pathology in vivo Alzheimers Dement. (IF 13.0) Pub Date : 2024-09-11 Alexa Pichet Binette, Angela Mammana, Laura Wisse, Marcello Rossi, Olof Strandberg, Ruben Smith, Niklas Mattsson-Carlgren, Shorena Janelidze, Sebastian Palmqvist, , Alice Ticca, Erik Stomrud, Piero Parchi, Oskar Hansson
We examined the relations of misfolded alpha synuclein (α-synuclein) with Alzheimer's disease (AD) biomarkers in two large independent cohorts.
-
Overview of ADNI MRI Alzheimers Dement. (IF 13.0) Pub Date : 2024-09-11 Clifford R. Jack, Arvin Arani, Bret J. Borowski, Dave M. Cash, Karen Crawford, Sandhitsu R. Das, Charles DeCarli, Evan Fletcher, Nick C. Fox, Jeffrey L. Gunter, Ranjit Ittyerah, Danielle J. Harvey, Neda Jahanshad, Pauline Maillard, Ian B. Malone, Talia M. Nir, Robert I. Reid, Denise A. Reyes, Christopher G. Schwarz, Matthew L. Senjem, David L. Thomas, Paul M. Thompson, Duygu Tosun, Paul A. Yushkevich
The magnetic resonance imaging (MRI) Core has been operating since Alzheimer's Disease Neuroimaging Initiative's (ADNI) inception, providing 20 years of data including reliable, multi-platform standardized protocols, carefully curated image data, and quantitative measures provided by expert investigators. The overarching purposes of the MRI Core include: (1) optimizing and standardizing MRI acquisition
-
Factors associated with cognitive reserve according to education level Alzheimers Dement. (IF 13.0) Pub Date : 2024-09-10 Yeshin Kim, Yaakov Stern, Sang Won Seo, Duk L. Na, Jae-Won Jang, Hyemin Jang
We investigated distinctive factors associated with cognitive reserve (CR) based on education level.
-
Hypertension and cerebral blood flow in the development of Alzheimer's disease Alzheimers Dement. (IF 13.0) Pub Date : 2024-09-10 Dario Bachmann, Antje Saake, Sandro Studer, Andreas Buchmann, Katrin Rauen, Esmeralda Gruber, Lars Michels, Roger M. Nitsch, Christoph Hock, Anton Gietl, Valerie Treyer
We investigated the interactive associations between amyloid and hypertension on the entorhinal cortex (EC) tau and atrophy and the role of cerebral blood flow (CBF) as a shared mechanism by which amyloid and hypertension contribute to EC tau and regional white matter hyperintensities (WMHs).
-
Amygdala atrophies in specific subnuclei in preclinical Alzheimer's disease Alzheimers Dement. (IF 13.0) Pub Date : 2024-09-10 Yasmine Salman, Thomas Gérard, Lara Huyghe, Lise Colmant, Lisa Quenon, Vincent Malotaux, Adrian Ivanoiu, Renaud Lhommel, Laurence Dricot, Bernard J. Hanseeuw
Magnetic resonance imaging (MRI) segmentation algorithms make it possible to study detailed medial temporal lobe (MTL) substructures as hippocampal subfields and amygdala subnuclei, offering opportunities to develop biomarkers for preclinical Alzheimer's disease (AD).
-
Tau phosphorylation correlates with multiple sclerosis disease course Nat. Rev. Neurol. (IF 28.2) Pub Date : 2024-09-12 Heather Wood
New research adds to growing evidence of altered tau phosphorylation in multiple sclerosis.
-
Hijacked macrophages sustain glioblastoma cells Nat. Rev. Neurol. (IF 28.2) Pub Date : 2024-09-12 Ian Fyfe
Metabolic rewiring of a population of tumour-associated macrophages facilitates progression of glioblastoma, new research has revealed. A multi-omics approach demonstrated that the macrophages develop a lipid-laden phenotype, in which they accumulate cholesterol after uptake of myelin debris. Transfer of this accumulated cholesterol to glioblastoma cells helps to meet the high metabolic requirements
-
Free DNA activates secondary stroke mechanism Nat. Rev. Neurol. (IF 28.2) Pub Date : 2024-09-12 Ian Fyfe
After a stroke, circulating, cell-free DNA causes inflammasome activation in atherosclerotic plaques that can lead to recurrent stroke, work in a mouse model has shown. In a model of stroke-induced recurrent ischaemia, increased inflammation in plaques in the common carotid artery resulted from activation of the AIM2 inflammasome by cell-free DNA that primarily originated from neutrophil extracellular
-
Adaptive deep brain stimulation shows promise Nat. Rev. Neurol. (IF 28.2) Pub Date : 2024-09-12 Ian Fyfe
Adaptive deep brain stimulation (DBS) improves motor symptoms and quality of life in people with Parkinson disease compared with continuous DBS, the results of a pilot trial suggest. The study included four people with Parkinson disease, each of whom received continuous and adaptive DBS at different times to enable comparison of the effects. Adaptive stimulation was personalized according to motor
-
Blood profile indicates central inflammation in frontotemporal lobar degeneration Nat. Rev. Neurol. (IF 28.2) Pub Date : 2024-09-12 Ian Fyfe
A pro-inflammatory serum profile has been associated with frontotemporal lobar degeneration (FLTD) in new research, increasing the likelihood that blood-based biomarkers can be used for assessment of neuroinflammation in people with dementia. The researchers analysed cytokines in the serum of 214 people with syndromes associated with FTLD and 29 healthy individuals. Their analysis identified a profile
-
Combining cerebrospinal fluid and PI‐2620 tau‐PET for biomarker‐based stratification of Alzheimer's disease and 4R‐tauopathies Alzheimers Dement. (IF 13.0) Pub Date : 2024-09-12 Roxane Dilcher, Stephan Wall, Mattes Groß, Sabrina Katzdobler, Olivia Wagemann, Carla Palleis, Endy Weidinger, Urban Fietzek, Alexander Bernhardt, Carolin Kurz, Christian Ferschmann, Maximilian Scheifele, Mirlind Zaganjori, Johannes Gnörich, Katharina Bürger, Daniel Janowitz, Boris‐Stephan Rauchmann, Sophia Stöcklein, Peter Bartenstein, Victor Villemagne, John Seibyl, Osama Sabri, Henryk Barthel, Robert
INTRODUCTIONRecent advances in biomarker research have improved the diagnosis and monitoring of Alzheimer's disease (AD), but in vivo biomarker‐based workflows to assess 4R‐tauopathy (4RT) patients are currently missing. We suggest a novel biomarker‐based algorithm to characterize AD and 4RTs.METHODSWe cross‐sectionally assessed combinations of cerebrospinal fluid measures (CSF p‐tau181 and t‐tau)
-
Detection of sex‐specific glutamate changes in subregions of hippocampus in an early‐stage Alzheimer's disease mouse model using GluCEST MRI Alzheimers Dement. (IF 13.0) Pub Date : 2024-09-12 Narayan Datt Soni, Anshuman Swain, Halvor Juul, Quy Cao, Mohammad Haris, David A. Wolk, Virginia M.‐Y. Lee, John A. Detre, Ravi Prakash Reddy Nanga, Ravinder Reddy
INTRODUCTIONRegional glucose hypometabolism resulting in glutamate loss has been shown as one of the characteristics of Alzheimer's disease (AD). Because the impact of AD varies between the sexes, we utilized glutamate‐weighted chemical exchange saturation transfer (GluCEST) magnetic resonance imaging (MRI) for high‐resolution spatial mapping of cerebral glutamate and investigated subregional changes
-
Cognitive resilience to Alzheimer's disease characterized by cell‐type abundance Alzheimers Dement. (IF 13.0) Pub Date : 2024-09-12 Nicholas O'Neill, Thor D. Stein, Oluwatosin A. Olayinka, Jenny A. Empawi, Junming Hu, Tong Tong, Xiaoling Zhang, Lindsay A. Farrer
INTRODUCTIONThe molecular basis of cognitive resilience (CR) among pathologically confirmed Alzheimer's disease (AD) cases is not well understood.METHODSAbundance of 13 cell types and neuronal subtypes in brain bulk RNA‐seq data from the anterior caudate, dorsolateral prefrontal cortex (DLPFC), and posterior cingulate cortex (PCC) obtained from 434 AD cases, 318 cognitively resilient AD cases, and
-
Integrated analyses reveal two molecularly and clinically distinct subtypes of H3 K27M-mutant diffuse midline gliomas with prognostic significance Acta Neuropathol. (IF 9.3) Pub Date : 2024-09-10 Lotte Stegat, Alicia Eckhardt, Antonia Gocke, Sina Neyazi, Lara Pohl, Simone Schmid, Matthias Dottermusch, Stephan Frank, Hans Pinnschmidt, Jochen Herms, Markus Glatzel, Matija Snuderl, Leonille Schweizer, Christian Thomas, Julia Neumann, Mario M. Dorostkar, Ulrich Schüller, Annika K. Wefers
-
HOXD12 defines an age-related aggressive subtype of oligodendroglioma Acta Neuropathol. (IF 9.3) Pub Date : 2024-09-11 Nicholas Nuechterlein, Sadie Cimino, Allison Shelbourn, Vinny Ha, Sonali Arora, Sharika Rajan, Linda G. Shapiro, Eric C. Holland, Kenneth Aldape, Tresa McGranahan, Mark R. Gilbert, Patrick J. Cimino
-
Autophagy–lysosomal-associated neuronal death in neurodegenerative disease Acta Neuropathol. (IF 9.3) Pub Date : 2024-09-11 Ralph A. Nixon
-
Pituitary adenylate cyclase-activating polypeptide signalling as a therapeutic target in migraine Nat. Rev. Neurol. (IF 28.2) Pub Date : 2024-09-10 Håkan Ashina, Rune H. Christensen, Debbie L. Hay, Amynah A. Pradhan, Jan Hoffmann, Dora Reglodi, Andrew F. Russo, Messoud Ashina
-
Increases in amyloid-β42 slow cognitive and clinical decline in Alzheimer’s disease trials Brain (IF 10.6) Pub Date : 2024-09-11 Jesus Abanto, Alok K Dwivedi, Bruno P Imbimbo, Alberto J Espay
Positive effects of new anti-amyloid-β (Aβ) monoclonal antibodies in Alzheimer’s disease (AD) have been attributed to brain amyloid reduction. However, most anti-Aβ antibodies also increase the CSF levels of the 42-amino acid isoform (Aβ42). We evaluated the associations of changes in CSF Aβ42 and brain Aβ-PET with cognitive and clinical end points in randomized trials of anti-Aβ drugs that lowered
-
Piezo2 channels and tactile pain: an intriguing voltage connection Brain (IF 10.6) Pub Date : 2024-09-11 Jorge Fernández-Trillo, Ana Gomis, Félix Viana
This scientific commentary refers to ‘Piezo2 voltage-block regulates mechanical pain sensitivity’ by Sánchez-Carranza et al. (https://doi.org/10.1093/brain/awae227).
-
-
Association Between Abnormal Sleep Duration and Stroke in the United States. Neurology (IF 7.7) Pub Date : 2024-09-11 Sara Hassani,Bruce Ovbiagele,Daniela Markovic,Amytis Towfighi
INTRODUCTION The new American Heart Association Life's Essential 8 construct of ideal cardiovascular health now includes sleep duration. Little is known, however, about sleep duration in individuals with prior stroke. Our objective was to compare sleep duration among individuals with and without prior stroke. METHODS Using the National Health and Nutrition Examination Surveys (NHANES) database (2005-2018)
-
Consensus Guidance for Genetic Counseling in GBA1 Variants: A Focus on Parkinson's Disease Mov. Disord. (IF 7.4) Pub Date : 2024-09-11 Sophia R.L. Vieira, Roxana Mezabrovschi, Marco Toffoli, Sara Lucas Del Pozo, Elisa Menozzi, Stephen Mullin, Selen Yalkic, Naomi Limbachiya, Sofia Koletsi, Nadine Loefflad, Grisel J. Lopez, Ziv Gan‐Or, Roy N. Alcalay, Ellen Sidransky, Anthony H.V. Schapira
Glucocerebrosidase (GBA1) variants constitute numerically the most common known genetic risk factor for Parkinson's disease (PD) and are distributed worldwide. Access to GBA1 genotyping varies across the world and even regionally within countries. Guidelines for GBA1 variant counseling are evolving. We review the current knowledge of the link between GBA1 and PD, and discuss the practicalities of GBA1
-
Multiciliated ependymal cells: an update on biology and pathology in the adult brain Acta Neuropathol. (IF 9.3) Pub Date : 2024-09-10 Adam M. R. Groh, Yeji Lori Song, Fiona Tea, Brianna Lu, Stephanie Huynh, Elia Afanasiev, Maxime Bigotte, Marc R. Del Bigio, Jo Jo Anne Stratton
-
Assessing disease progression and treatment response in progressive multiple sclerosis Nat. Rev. Neurol. (IF 28.2) Pub Date : 2024-09-09 Giancarlo Comi, Gloria Dalla Costa, Bruno Stankoff, Hans-Peter Hartung, Per Soelberg Sørensen, Patrick Vermersch, Letizia Leocani
Progressive multiple sclerosis poses a considerable challenge in the evaluation of disease progression and treatment response owing to its multifaceted pathophysiology. Traditional clinical measures such as the Expanded Disability Status Scale are limited in capturing the full scope of disease and treatment effects. Advanced imaging techniques, including MRI and PET scans, have emerged as valuable
-
Genetic spectrum features and diagnostic accuracy of four plasma biomarkers in 248 Chinese patients with frontotemporal dementia Alzheimers Dement. (IF 13.0) Pub Date : 2024-09-10 Tianyan Xu, Ling Weng, Cong Zhang, Xuewen Xiao, Qijie Yang, Yuan Zhu, Yafang Zhou, Xinxin Liao, Shilin Luo, Junling Wang, Beisha Tang, Bin Jiao, Lu Shen
INTRODUCTIONFrontotemporal dementia (FTD) is characterized by phenotypic and genetic heterogeneities. However, reports on the large Chinese FTD cohort are lacking.METHODSTwo hundred forty‐eight patients with FTD were enrolled. All patients and 2010 healthy controls underwent next generation sequencing. Plasma samples were analyzed for glial fibrillary acidic protein (GFAP), α‐synuclein (α‐syn), neurofilament
-
Gender differences in the association between education and late‐life cognitive function in the LifeAfter90 Study: A multiethnic cohort of the oldest–old Alzheimers Dement. (IF 13.0) Pub Date : 2024-09-10 Jennifer O. Lam, Rachel A. Whitmer, Maria M. Corrada, Claudia H. Kawas, Katherine E. Vieira, Charles P. Quesenberry, Paola Gilsanz
INTRODUCTIONFew studies have examined the relationship between education and cognition among the oldest–old.METHODSCognitive assessments were conducted biannually for 803 participants (62.6% women) of LifeAfter90, a longitudinal study of individuals ≥ 90 years old. Gender differences in associations between education (< high school, high school, some college, and ≥ college) and cognition (verbal episodic
-
An algorithm for drug-resistant epilepsy in Danish national registers Brain (IF 10.6) Pub Date : 2024-09-10 Eva Bølling-Ladegaard, Julie W Dreier, Jakob Christensen
Patients with drug-resistant epilepsy (DRE) have increased risks of premature death, injuries, psychosocial dysfunction, and a reduced quality of life. Identification of persons with DRE in administrative data can allow for effective large-scale research, and we therefore aimed to construct an algorithm for identification of DRE in Danish nation-wide health registers. We used a previously generated
-
-
Reader Response: Fine Particulate Matter and Parkinson Disease Risk Among Medicare Beneficiaries. Neurology (IF 7.7) Pub Date : 2024-09-10 Michelle You,Lauren Grobois,Mill Etienne
-
Reader Response: Fine Particulate Matter and Parkinson Disease Risk Among Medicare Beneficiaries. Neurology (IF 7.7) Pub Date : 2024-09-10 Steven R Brenner
-
Thrombolysis After Dabigatran Reversal for Acute Ischemic Stroke: A National Registry-Based Study and Meta-Analysis. Neurology (IF 7.7) Pub Date : 2024-09-10 Aikaterini Theodorou,Konstantinos Melanis,Eleni Bakola,Maria Chondrogianni,Argyro Kiamili,Panagiotis Plomaritis,Klearchos Psychogios,Apostolos Safouris,Odysseas Kargiotis,Evangelos Ntais,Maria-Ioanna Stefanou,Lina Palaiodimou,Amrou Sarraj,David J Seiffge,Sotirios Giannopoulos,Georgios Tsivgoulis
BACKGROUND AND OBJECTIVES Limited data exist on the safety of IV thrombolysis (IVT) for acute ischemic stroke (AIS) after dabigatran reversal with idarucizumab. We sought to evaluate the safety and efficacy of idarucizumab pretreatment in patients with AIS receiving IVT. METHODS A national registry-based study evaluated the safety and efficacy of IVT in this specific subgroup. We also conducted a systematic
-
Pearls & Oy-sters: Tumour-Like Mass Lesion Secondary to Primary CNS Vasculitis. Neurology (IF 7.7) Pub Date : 2024-09-10 Jodie I Roberts,Denise Ng,Ronak Kapadia
Primary CNS vasculitis (PCNSV) is uncommonly considered in the differential diagnosis of tumor-like lesions. This case report of tumefactive PCNSV highlights imaging features that should increase clinical suspicion for CNS vasculitis, potentially lending to earlier diagnosis and treatment. A 62-year-old man presented with a 1-month history of focal motor seizures and cortical sensory loss localizing
-
Author Response: Fine Particulate Matter and Parkinson Disease Risk Among Medicare Beneficiaries. Neurology (IF 7.7) Pub Date : 2024-09-10 Brittany Krzyzanowski
-
Editors' Note: Fine Particulate Matter and Parkinson Disease Risk Among Medicare Beneficiaries. Neurology (IF 7.7) Pub Date : 2024-09-10 Ariane Lewis,Steven L Galetta
-
Author Response: Fine Particulate Matter and Parkinson Disease Risk Among Medicare Beneficiaries. Neurology (IF 7.7) Pub Date : 2024-09-10 Brittany Krzyzanowski
-
Cluster-Based White Matter Signatures and the Risk of Dementia, Stroke, and Mortality in Community-Dwelling Adults. Neurology (IF 7.7) Pub Date : 2024-09-10 Mathijs T Rosbergen,Frank J Wolters,Elisabeth J Vinke,Francesco U S Mattace-Raso,Gennady V Roshchupkin,Mohammad Arfan Ikram,Meike W Vernooij
BACKGROUND AND OBJECTIVES Markers of white matter (WM) injury on brain MRI are important indicators of brain health. Different patterns of WM atrophy, WM hyperintensities (WMHs), and microstructural integrity could reflect distinct pathologies and disease risks, but large-scale imaging studies investigating WM signatures are lacking. This study aims to identify distinct WM signatures using brain MRI
-
Amelioration of Focal Hand Dystonia via Low‐Frequency Repetitive Somatosensory Stimulation Mov. Disord. (IF 7.4) Pub Date : 2024-09-10 Lorenzo Rocchi, Anna Latorre, Elisa Menozzi, Vittorio Rispoli, John C. Rothwell, Alfredo Berardelli, Kailash P. Bhatia
BackgroundDystonia presents a growing concern based on evolving prevalence insights. Previous research found that, in cervical dystonia, high‐frequency repetitive somatosensory stimulation (RSS; HF‐RSS) applied on digital nerves paradoxically diminishes sensorimotor inhibitory mechanisms, whereas low‐frequency RSS (LF‐RSS) increases them. However, direct testing on affected body parts was not conducted
-
Role of the X Chromosome in Alzheimer Disease Genetics JAMA Neurol. (IF 20.4) Pub Date : 2024-09-09 Michael E. Belloy, Yann Le Guen, Ilaria Stewart, Kennedy Williams, Joachim Herz, Richard Sherva, Rui Zhang, Victoria Merritt, Matthew S. Panizzon, Richard L. Hauger, J. Michael Gaziano, Mark Logue, Valerio Napolioni, Michael D. Greicius
ImportanceThe X chromosome has remained enigmatic in Alzheimer disease (AD), yet it makes up 5% of the genome and carries a high proportion of genes expressed in the brain, making it particularly appealing as a potential source of unexplored genetic variation in AD.ObjectivesTo perform the first large-scale X chromosome–wide association study (XWAS) of AD.Design, Setting, and ParticipantsThis was a
-
Incident Epilepsy Among US Medicare Beneficiaries, 2019: Differences by Age, Sex, and Race/Ethnicity. Neurology (IF 7.7) Pub Date : 2024-09-09 David F Warner,Hannah L Fein,Nicholas K Schiltz,Long Vu,Magdalena Szaflarski,Wyatt P Bensken,Martha Sajatovic,Gena Ghearing,Siran Koroukian
BACKGROUND AND OBJECTIVES Epilepsy is common among older adults, but previous incident studies have had limited ability to make comparisons across key subgroups. We aimed to provide updated epilepsy incidence estimates among older adults, comparing across age, sex, and race/ethnicity. METHODS Using a random sample of 4,999,999 US Medicare beneficiaries older than 65 years, we conducted a retrospective
-
Association of Normative and Non-Normative Brain Networks With Cognitive Function in Patients With Temporal Lobe Epilepsy. Neurology (IF 7.7) Pub Date : 2024-09-09 Qirui Zhang,Stacy Hudgins,Aaron F Struck,Ankeeta Ankeeta,Sam S Javidi,Michael R Sperling,Bruce P Hermann,Joseph I Tracy
BACKGROUND AND OBJECTIVES Despite their temporal lobe pathology, a significant subgroup of patients with temporal lobe epilepsy (TLE) is able to maintain normative cognitive functioning. In this study, we identify patients with TLE with intact vs impaired neurocognitive profiles and interrogate for the presence of both normative and highly individual intrinsic connectivity networks (ICNs)-all toward
-
Imaging Evolution of the Development of Dural Arteriovenous Fistula. Neurology (IF 7.7) Pub Date : 2024-09-09 Victor M De Carvalho,Bruno Shigueo Y Inada,Christiane M De Siqueira Campos,Fabricio T Romagnol,Thomas A Yasuda
-
Pearls & Oy-sters: Exquisite Response of Sleep-Related Hypermotor Epilepsy to a Nicotine Patch. Neurology (IF 7.7) Pub Date : 2024-09-09 Spencer Nam,Erica L Von Stein,Kimford J Meador,Rebecca J Levy,William Gallentine,Yi Li
Sleep-related hypermotor epilepsy (SHE), previously known as nocturnal frontal lobe epilepsy, is characterized by brief (<2 minutes) seizures with abrupt onset and offset and stereotyped focal or generalized hypermotor events occurring predominantly (but not exclusively) from sleep. Clinically, SHE can be challenging to distinguish from psychogenic nonepileptic events or sleep disorders. Up to 30%